These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20693835)

  • 1. Positron emission tomography with 18F-fluorodeoxyglucose is a useful tool for the diagnosis of pheochromocytomas without distant metastasis, where malignancy is suspected on the basis of histopathologic analysis.
    Kikuchi F; Imachi H; Murao K; Ohyama T; Miyai Y; Kushida Y; Haba R; Kakehi Y; Ishida T
    Am J Med Sci; 2010 Aug; 340(2):160-3. PubMed ID: 20693835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case of 131I-meta-iodobenzylguanidine (MIBG) scintigraphy-negative and 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)-positive pheochromocytoma].
    Jotoku M; Okura T; Nagao T; Enomoto D; Irita J; Miyoshi K; Kurata M; Fukuoka T; Higaki J
    Nihon Jinzo Gakkai Shi; 2009; 51(5):563-8. PubMed ID: 19715165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
    Mann GN; Link JM; Pham P; Pickett CA; Byrd DR; Kinahan PE; Krohn KA; Mankoff DA
    Ann Surg Oncol; 2006 Feb; 13(2):187-97. PubMed ID: 16418883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
    Lugat A; Drui D; Mirallié E; Kraeber-Bodéré F; Ansquer C
    Clin Nucl Med; 2019 Sep; 44(9):738-740. PubMed ID: 31306205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
    Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K
    J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.
    Shulkin BL; Koeppe RA; Francis IR; Deeb GM; Lloyd RV; Thompson NW
    Radiology; 1993 Mar; 186(3):711-5. PubMed ID: 8430179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy.
    Ezuddin S; Fragkaki C
    Clin Nucl Med; 2005 Aug; 30(8):579-81. PubMed ID: 16024963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
    Shulkin BL; Thompson NW; Shapiro B; Francis IR; Sisson JC
    Radiology; 1999 Jul; 212(1):35-41. PubMed ID: 10405717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
    Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K
    Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
    Hadi M; Chen CC; Whatley M; Pacak K; Carrasquillo JA
    J Nucl Med; 2007 Jul; 48(7):1077-83. PubMed ID: 17574980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Factors of Early 18F-Fluorodeoxyglucose-Positron Emission Tomography Response to [131I] Metaiodobenzylguanidine Treatment for Unresectable or Metastatic Pheochromocytomas and Paragangliomas.
    Takenaka J; Watanabe S; Abe T; Tsuchikawa T; Takeuchi S; Hirata K; Kimura R; Wakabayashi N; Shinohara N; Kudo K
    Neuroendocrinology; 2024; 114(9):816-826. PubMed ID: 37725921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case Report : FDG Uptake to Brown Adipose Tissue Activated by Elevated Serum Catecholamine in a Patient with Pheochromocytoma].
    Koh Y; Asakura T; Katayama K; Tei N; Harada Y; Nishimura K
    Hinyokika Kiyo; 2018 Nov; 64(11):435-438. PubMed ID: 30543742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction.
    Defeudis G; Fioriti E; Palermo A; Tuccinardi D; Minucci A; Capoluongo E; Pozzilli P; Manfrini S
    Hormones (Athens); 2018 Jun; 17(2):279-284. PubMed ID: 29860716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma.
    Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET in the evaluation of phaeochromocytoma: a correlative study with MIBG scintigraphy and Ki-67 proliferative index.
    Lin M; Wong V; Yap J; Jin R; Leong P; Campbell P
    Clin Imaging; 2013; 37(6):1084-8. PubMed ID: 24035263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality imaging of bilateral pheochromocytoma. A case report.
    Paladino NC; Lowery A; Guérin C; Taïeb D; Sebag F
    Ann Ital Chir; 2015 Jun; 86(ePub):. PubMed ID: 26208532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of a pheochromocytoma using I-123 MIBG adrenal scintigraphy.
    Shirkare S; Kuwert T; Weckesser M; Czech N; Langen KJ; Muller-Gartner HW
    J Postgrad Med; 1994; 40(2):85-7. PubMed ID: 8737560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.